MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. MHUAF

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $61.79M, -36.2% YoY · Filed Apr 29, 2026

MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $61.8 million and net income of $6.8 million. Free cash flow was $554,254. As of Dec 31, 2025 it held $38.6 million in cash and investments and $9.0 million in total debt.

Revenue
$61.79M
-36.2% vs prior year
Net income
$6.78M
-37.5% vs prior year
Operating cash flow
$569,883
-96.1% vs prior year
Free cash flow
$554,254
-96.2% vs prior year
EPS
$18.04
-62.9% vs prior year
Dividend per share
None
Shares outstanding
697,914
-97.8% vs prior year
Net cash
$29.62M
FY 2025
Operating margin
13.4%
FY 2025

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MHUAF (OTC)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Yangzhou, China
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1835615

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$61.8M
$96.9M
$97.1M
$103.3M
$104.0M
Operating income
$8.3M
$14.3M
$14.7M
$10.8M
$26.3M
Net income
$6.8M
$10.8M
$11.6M
$6.2M
$20.9M
Diluted EPS
$18.04
—
$48.56
$0.27
—
Operating cash flow
$569,883
$14.6M
$2.3M
-$9.2M
-$54,663
Free cash flow
$554,254
$14.5M
$1.1M
-$11.9M
-$904,894
Total assets
$207.2M
$186.2M
$171.9M
$163.6M
$136.9M
Total liabilities
—
$27.3M
$25.1M
$24.9M
$29.1M
Stockholders' equity
$188.9M
$159.0M
$146.3M
$138.1M
$107.8M
Cash and investments
$38.6M
$38.3M
$6.1M
$33.4M
$9.1M
Total debt
$9.0M
$7.9M
$7.3M
$6.8M
$5.2M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Jun 26, 2026 Jun 26, 2026
20-F Annual report (foreign issuer) Apr 29, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 2, 2026 Mar 2, 2026
6-K Current report (foreign issuer) Feb 2, 2026 Feb 2, 2026
6-K Current report (foreign issuer) Jan 23, 2026 Jan 22, 2026
6-K/A Amendment no. 1 to form 6-k Jan 20, 2026 Jan 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.